Professor Dean Ho is Provost’s Chair Professor, Director of The N.1 Institute for Health, Director of The Institute for Digital Medicine (WisDM) and Head of the Department of Biomedical Engineering at the National University of Singapore
Prof Ho and collaborators successfully developed and validated CURATE.AI, which develops digital twins to personalise treatment. He co-led the first CURATE.AI clinical trials, which have resulted in life-saving outcomes.
In October of 2024, Prof. Ho and team launched DELTA, a first-in-kind human trial - with Prof. Ho as the test subject. This N-of-1 protocol harnesses a combination of AI, fasting, fitness, and food to optimise metabolic health, monitored using an array of digital health platforms. This unprecedented study will culminate in a digital twin of Prof Ho to hyper-personalise his cardiometabolic health protocol. Learnings from DELTA will be used to design population-scale healthspan trials.
Prof Ho is an elected member of the US National Academy of Inventors, American Association for the Advancement of Science, American Institute for Medical and Biological Engineering, and Royal Society of Chemistry. He has appeared on the National Geographic Channel Program “Known Universe,” and his discoveries have been featured on CNN, The Economist, Forbes, Washington Post, NPR and other international news outlets. Prof Ho is Co-Chair of the World Health Organization AI for Health Working Group for Regulatory Considerations.